cefixime has been researched along with Osteomyelitis in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohzari, YA | 1 |
| Alshuraim, R | 1 |
| Asdaq, SMB | 1 |
| Aljobair, F | 1 |
| Alrashed, A | 1 |
| Alsowaida, YS | 1 |
| Alamer, A | 2 |
| Al Munjem, MF | 1 |
| Al Musawa, MI | 1 |
| Hatata, M | 1 |
| Alzaaqi, MA | 1 |
| Binrokan, A | 1 |
| Alajlan, SA | 1 |
| Abraham, I | 1 |
1 other study available for cefixime and Osteomyelitis
| Article | Year |
|---|---|
Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Cefixime; Child; Humans; Male; Osteomyelitis; Prospectiv | 2022 |